Biocytogen

Biocytogen

Biocytogen’s preclinical service division, BioMice, encompasses the generation and provision of off-the-shelf humanized and/or immunodeficient animal and cell model products, a variety of preclinical pharmacology services, and custom gene-editing services to clients in academia and industry. Biocytogen’s R&D division, RenBiologics, focuses on discovery and out-licensing novel antibodies to worldwide partners in the biotechnology and biopharmaceutical sectors for therapeutic development.